Drug Discovery Industry Review

Report Code: PHM001D

Publish Date: Jul 2003

Publisher: BCC Publishing

Category: Pharmaceuticals

Customize This Report

Single User License: $2500

Member Price: FREE

Explore Our Services

Already a member? Login to access this report free.

Report Highlights

INTRODUCTION

Drug discovery technology involves innumerable assays to determine the molecular affinities and potential toxic effects of drug candidates. In the past decade, through the application of combinatorial chemistry and genomics, the number of drug candidates has increases logarithmically. To sort through these now astronomical numbers of potential blockbusters, the pharmaceutical industry has applied increasingly miniaturized and robotic assays systems.

Miniaturization not only saves on scarce resources, such as purified proteins, but also decreases the time, another precious commodity, involved in doing assays.

Nanotechnology involves the miniaturization of devices beyond microengineering; however, at nanoscale, materials can have quite different properties, as different physical principles, for instance, van der Wall's forces, become more dominant. Intuitive understanding of forces like friction or surface tension are not useful at the nano level. Nanostructured materials may be very much stronger and lighter than conventional bulk materials. Some nanostructured materials have new and unexpected properties, such as "quantum dots" that fluoresce at different wavelengths depending upon their size. Nanomaterials may be used to create nanodevices with defined functions.

Biomolecules such as protein and DNA are also easily exploited to make nanodevices. Like fullerenes, biomolecules generally have a carbon backbone, but one that is widely substituted with modifiable chemical groups. Because their biochemistry is well understood, DNA and proteins are being used structurally now to build nanodevices.

The favorite manufactured items used by nanotechnologists have diameters comparable to smallest objects found in nature. Six-carbon atoms lined end to end are about 1 nm in diameter. Perhaps surprisingly, the synthetic molecule, buckminster fullerene, which contains 60 carbons, has the same diameter. Despite the large molecular weight, because C60 is approximately spherical is minimal. Even so, C60 can be made to cage other molecules, including some used for medical imaging purposes. Fullerene derivatives, such as nanotubes, have smaller diameters than C60. Commercially available nanoparticles are actually quite a bit smaller than cells, about the same size as an average virus.

It is apparent that nanoscale fabrication has already reached the scale of biomolecules. The problem that remains is how to apply nanotechnology to biomedical requirements, and even more difficult, how to make it marketable. Nanoscale devices are now being used for contrast agents for imaging purposes, for bioassays, as drug delivery agents, and even as drug equivalents.
Need a custom data table, graph, region, segment, companies or complete report? CUSTOMIZE NOW
Let us assist you! Our analysts are ready to tailor this report to your specific need. REACH OUT TO US TODAY

Table of Contents

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
Title/Chapter NamePagesMember Price
Full Report: Drug Discovery Industry Review300Free
Chapter- 1: INTRODUCTION/SUMMARY2Free
Chapter- 2: ARTIFICIAL CELLS3Free
Chapter- 3: BASIC SCIENCE27Free
Chapter- 4: BIOINFORMATICS10Free
Chapter- 5: BIOMIMETICS5Free
Chapter- 6: COLLABORATIONS15Free
Chapter- 7: COMPUTING1Free
Chapter- 8: CONFERENCE REPORT5Free
Chapter- 9: DESIGNER MACROMOLECULES5Free
Chapter- 10: DIAGNOSTICS AND ANALYTICS25Free
Chapter- 11: DRUG AND VACCINE DELIVERY21Free
Chapter- 12: DRUG DISCOVERY1Free
Chapter- 13: DRUG TARGETS23Free
Chapter- 14: IMAGING6Free
Chapter- 15: IMPLANTS3Free
Chapter- 16: INDUSTRY NEWS59Free
Chapter- 17: INDUSTRY OUTLOOK5Free
Chapter- 18: INFORMATICS12Free
Chapter- 19: MEMS AND NEMS3Free
Chapter- 20: MODELING2Free
Chapter- 21: NANOASSEMBLY1Free
Chapter- 22: NANOPARTICLES2Free
Chapter- 23: NANOTUBES AND NANOWIRES3Free
Chapter- 24: NEW COMPOUNDS30Free
Chapter- 25: OLD COMPOUNDS1Free
Chapter- 26: PATENTS3Free
Chapter- 27: PEPTIDES1Free
Chapter- 28: PROTEOMICS14Free
Chapter- 29: RATIONAL DRUG DESIGN4Free
Chapter- 30: SCREENING5Free
Chapter- 31: SEMICONDUCTORS1Free
Chapter- 32: THIN FILMS2Free

Related Reports

Recent Reports

Gastrointestinal Therapeutics and Diagnostics: Technologies and Global Markets

Published - Apr 2024 | Publisher - BCC Publishing | Code - PHM046D

The global market for gastrointestinal (GI) therapeutics and diagnostics is expected to grow from $86.0 billion in 2023 and projected to reach $122.5 billion by the end of 2028, at a compound annual growth rate (CAGR) of 7.3% during the forecast period of 2023 to 2028.

Global Markets and Technologies for Advanced Drug Delivery Systems

Published - Mar 2024 | Publisher - BCC Publishing | Code - PHM006N

The global market for advanced drug delivery systems is expected to increase from $262.6 billion in 2023 to $359.1 billion by the end of 2028, with a compound annual growth rate (CAGR) of 6.5% during the forecast period of 2023-2028.

Prevention and Treatment of Prostate Cancer: Technologies and Global Markets

Published - Feb 2024 | Publisher - BCC Publishing | Code - PHM113C

The global market for prostate cancer care is expected to grow from $37.9 billion in 2023 to $56.4 billion by the end of 2028, at a compound annual growth rate (CAGR) of 8.3% from 2023 through 2028.

Global Markets for Vaccine Technologies

Published - Feb 2024 | Publisher - BCC Publishing | Code - PHM014K

The global market for vaccine technologies is expected to grow from $45.0 billion in 2023 to $65.3 billion by the end of 2028, at a compound annual growth rate (CAGR) of 7.8% from 2023 to 2028.

Chagas Disease: American trypanosomiasis Market

Published - Feb 2024 | Publisher - BCC Publishing | Code - PHM282A

The report provides detailed coverage of the Chagas Disease market. It analyzes the market trends and epidemiology of CD, and the regional markets of CD. It highlights the current market for CD and gives a detailed analysis of the competitive environment. The report depicts the complete scenario of Chagas Disease, types of parasites that cause human African trypanosomiasis (HAT) and its presence in various regions of the world.

Top Trending Reports

Cell and Gene Therapy Tools, and Reagents: Global Markets

Published - Nov 2022 | Publisher - BCC Publishing | Code - BIO208B

The global market for cell and gene therapy tools and reagents is estimated to grow from $8.3 billion in 2022 to $13.7 billion in 2027, with a compound annual growth rate (CAGR) of 10.6% for the period of 2022-2027.

Flame Retardant Chemicals: Technologies and Global Markets

Published - Nov 2022 | Publisher - BCC Publishing | Code - CHM014Q

The global consumption of flame retardant chemicals is estimated to grow from 6.0 billion pounds in 2022 to 7.5 billion pounds in 2027, at a compound annual growth rate (CAGR) of 4.4% for the period of 2022-2027.

Biorefinery Products: Global Markets

Published - Nov 2022 | Publisher - BCC Publishing | Code - EGY117D

The global market for biorefinery products is estimated to increase from $624.7 billion in 2022 to $920.0 billion by 2027, at a compound annual growth rate (CAGR) of 8.0% from 2022 through 2027.

Electric Vehicle Charging: Infrastructure and Global Markets

Published - Nov 2022 | Publisher - BCC Publishing | Code - FCB045B

The global market for wired electric vehicle charging infrastructure is estimated to grow from $24.1 billion in 2022 to $81.1 billion in 2027, at a compound annual growth rate (CAGR) of 27.4% for the period of 2022-2027.

Digital Pathology: Technologies and Global Markets

Published - Dec 2022 | Publisher - BCC Publishing | Code - HLC161D

The global digital pathology market is estimated to increase from $5.9 billion in 2022 to reach $10.7 billion by 2027, at a compound annual growth rate (CAGR) of 12.5% from 2022 through 2027.

Become A Member

BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.

Find Out More

Custom Consulting

BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.

Customize Now

Scorecard

The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.

Find Out More

Innovation Spotlight

Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.

Find Out More
Drug Discovery Industry Review
Customize Report